Please login to the form below
European Respiratory Society
This page shows the latest European Respiratory Society news and features for those working in and with pharma, biotech and healthcare.
Sanofi and Regeneron share positive data for asthma drug
The late-breaking data was presented at the European Respiratory Society (ERS) 2022 congress and demonstrated a consistent safety profile and efficacy for up to two years for children in this ... The safety results of the trial were generally consistent
Latest news
-
Qureight announces world’s first digital biomarker for lung fibrosis will ‘transform’ clinical trials
Presented at the European Respiratory Society meeting in Barcelona, the announcement marks the first time artificial intelligence (AI) using convolutional neural networks has been used to analyse trial data involving the
-
AZ hopes dosing will differentiate its severe asthma therapy
The UK pharma group reported the results of two studies at the European Respiratory Society (ERS) in London, which showed the interleukin-5 (IL-5) inhibitor was able to reduce attacks
-
Roche says Esbriet boosts survival in pulmonary fibrosis
Positive results due to be presented at European Respiratory Society . Data due to be reported at a medical conference next week shows Roche's Esbriet can improve survival in idiopathic pulmonary ... deal. The new data - due to be presented to doctors
-
Boehringer in breach over beer drinking, lederhosen presentation
standards. The breach comes after a pulmonologist working in Germany complained about a scientific symposium organised by Boehringer at the European Respiratory Society (ERS) Congress, held in Munich last year. ... Boehringer currently markets the
-
GSK sees COPD future in triple therapy
The performance of GSK's respiratory portfolio dragged down group revenues as a whole last year, and GSK is now banking on a series of new products launches - including LAMA/LABA ... One set back for the triple therapies came last year, however, when a
More from news
Approximately 1 fully matching, plus 17 partially matching documents found.
Latest Intelligence
-
Follow the user – democratising medical conference design
increased incrementally, the curve of the European Respiratory Society congress (22, 094 vs 33, 784) saw its 2019 demographic increased by more than 50%. ... Another look at the 2020 European Respiratory Society statistics illustrates the high value
-
Exploring the potential of eosinophils
This study was the first to investigate an anti-IL-5 therapy in patients with nasal polyps and the data was presented for the first time at the European Respiratory Society ... GSK has an extraordinary heritage in respiratory research to try to benefit
-
GSK forges ahead with its dynamic COPD and asthma portfolio
Other patient and clinical interest groups put the figure even higher, with the European Respiratory Society placing the number at 300 million, with figures rising higher in nations with poor access ... COPD was a Cinderella disease when I started in
-
The long and winding road to asthma breakthroughs
Respiratory biologics are booming thanks to scientists who refused to be derailed by early research setbacks. ... The company’s severe eosinophilic asthma biologic Nucala (mepoluzimab), an Interleukin-5 inhibitor, has been buoyed by a real-world
-
Case Study: COPD Crowdshaped
At the European Respiratory Society (ERS) congress 2015, we convened the world’s first three-university simultaneous hackathon with over 400 participants from Massachusetts Institute of Technology (MIT), Imperial College London
More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- Roche’s Polivy recommended by NICE for lymphoma therapy
- Sanofi/Regeneron’s Dupixent approved by EC for eosinophilic oesophagitis
- ASH 2022: bad blood but big advances
- AbbVie’s Rinvoq approved by MHRA for Crohn's disease
- GSK’s Benlysta given orphan drug status by FDA for systemic sclerosis
- AstraZeneca’s Imfinzi plus chemotherapy approved by MHRA for biliary tract cancer
- ICR calls for improved biomarker cancer tests to help personalise treatment
- EIT Health marks World Cancer Day with €6m pledge for new healthcare delivery models
- World Cancer Day: encouraging men to put their health first
- World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
- Strategic behaviour
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- Creabilis names Catherine Moukheibir as chairman of the board
- World Health Organization releases latest set of COVID-19 guidelines
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- MIT researchers develop AI model to detect future lung cancer risk
PMHub
Wave Healthcare Communications
Wave combine scientific, medical and brand expertise to deliver clinically focused programmes that are trusted by HCPs, drive better patient...
Latest intelligence
- World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
- Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
- Strategic behaviour
- Strong strategising depends on your colleagues’ behaviour...
- Pharmaceutical Marketing Strategies For The Digital Age
- In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...
